Overview Follow the Money Daily Brief Live Congress Directory Corporate Insiders Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist

Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology

Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…

Overview Follow the Money Daily Brief Live Congress Directory Corporate Insiders Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology

Overview Follow the Money Daily Brief Live Congress Directory Corporate Insiders Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist

Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology

Overview Follow the Money Daily Brief Live Congress Directory Corporate Insiders Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology

Data sources

SEC FORM 41h ago

HOUSE PTR1h ago

SEC 13F1h ago

ROBINHOOD CHAIN1h ago

Public company

EXELIXIS, INC.

EXELCIK 0000939767

EDGAR filings Open in network

Price$69.57

1 year+72.3%

Disclosed transactions0

Buys / sells0 / 0

Max Insider Score—

Connections with evidence6

EXEL · disclosed activity on price

Disclosed transactions

No records

No transactions recorded for this profile.

Verified connections

In industryevidence
Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
← Lobbied forevidence
W STRATEGIES, LLCLDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
← Lobbied forevidence
TODD STRATEGY GROUPLDA Q2 2026 second quarter · Health issues, Medicare/Medicaid, Copyright/patent · Aug 26, 2026
← Lobbied forevidence
ARNOLD & PORTER KAYE SCHOLER LLPLDA Q1 2026 first quarter · Medicare/Medicaid, Health issues · Aug 26, 2026
← Lobbied for

THORN RUN PARTNERS

LDA Q1 2026 first quarter · Health issues, Medicare/Medicaid · Aug 26, 2026

← Holdsevidence

RENAISSANCE TECHNOLOGIES LLC1.0% of reported portfolio · Aug 13, 2026

Lobbying

$1.08M reported · de-duplicated

2026 Q2 $560K in-house2026 Q1 $520K in-house

THORN RUN PARTNERS$60K2026 Q1 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid
W STRATEGIES, LLC—2026 Q2 · posted Aug 26, 2026 · Pharmacy
TODD STRATEGY GROUP$50K2026 Q1 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid, Copyright/patent
TODD STRATEGY GROUP$50K2026 Q2 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid, Copyright/patent
W STRATEGIES, LLC$60K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid
ARNOLD & PORTER KAYE SCHOLER LLP$60K2026 Q2 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid
In-house report$560K2026 Q2 · posted Aug 26, 2026 · Health issues, Taxation
THORN RUN PARTNERS$60K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid, Health issues
ARNOLD & PORTER KAYE SCHOLER LLP$60K2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid, Health issues
In-house report$520K2026 Q1 · posted Aug 26, 2026 · Health issues, Taxation

Connected PAC contributions

FEC · direct to members

No contributions from a PAC connected to this company.